Hakon Invest's position on Hemtex new share issue

Hakon Invest's position on Hemtex new share issue

ID: 48545

(Thomson Reuters ONE) -


Hemtex has today, in conjunction with publication of the company's report for
the third quarter, announced that the company intends to carry out a new share
issue with preferential rights for existing shareholders. This since the company
in October did not meet the terms in its loan agreement with the banks.

The details of the new issue will be published in conjunction with Hemtex's
year-end report on 15 February 2011. The new issue will be carried out during
the company's first quarter 2011. Until implementation of the new issue, the
banks have issued a bank guarantee, a so-called waiver. Hakon Invest guarantees
its share in the issue, 68.5% of the share capital, provided reasonable terms
apply.



For further information, please contact:

SVP Investments & Portfolio Companies
Stein Petter Ski
Tel: +46 8 55 33 99 44
stein-petter.ski(at)hakoninvest.se

CFO
Göran Blomberg
Tel: +46 8 55 33 99 99
göran.blomberg(at)hakoninvest.se


Head of IR
Cecilia Lannebo
Tel: +46 8 55 33 99 55
cecilia.lannebo(at)hakoninvest.se


The information is that which Hakon Invest AB is required to declare by the
Securities Business Act and/or the Financial instruments Trading Act. The
information was submitted for publication on November 9 at 07.00.



[HUG#1460029]





Hemtex 20101109ENG:
http://hugin.info/135965/R/1460029/399361.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.




Source: Hakon Invest AB via Thomson Reuters ONE


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Third quarter results 2010 for Wilh. Wilhelmsen ASA ABLYNX ELIGIBLE FOR MILESTONE PAYMENT AS PFIZER INITIATES PHASE I CLINICAL TRIAL WITH A SECOND ANTI-TNF-alpha NANOBODY
Bereitgestellt von Benutzer: hugin
Datum: 09.11.2010 - 07:03 Uhr
Sprache: Deutsch
News-ID 48545
Anzahl Zeichen: 2131

contact information:
Town:

Solna



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 180 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Hakon Invest's position on Hemtex new share issue"
steht unter der journalistisch-redaktionellen Verantwortung von

Hakon Invest AB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Interim report January - September 2009 ...

January 1- September 30, 2009 - Group revenues amounted to SEK 1,372 M (861). This represents an increase of 59.3% compared with the same period in 2008. The increase is mainly due to acquired operations. - Operating profit in the Group amounted to ...

Invitation to press and analyst meeting ...

Hakon Invest will release its interim report for January - September 2009 on Wednesday, November 4, 2009 and, consequently, is extending an invitation to a press and analyst meeting. Time: Wednesday, November 4, 2009, 10.30 a.m. Location: Salén Ko ...

Hakon Invest ranked second best in annual CDP survey ...

In the CDP's annual survey of how stock market-listed companies manage the climate issue, Hakon Invest was ranked second among Nordic companies. A total of 128 companies in the Nordic region participated in the survey. The Carbon Disclosure Pro ...

Alle Meldungen von Hakon Invest AB



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z